| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nexalin Technology, Inc. (NXL) has 8 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. NXL is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.48M | $864.7K | - | |
| CEO | 2.39M | $830.7K | - | |
| 10% | 1.62M | $563.3K | - | |
| Dir | 362.5K | $126.1K | - | |
| CFO | 230.4K | $80.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2025 | Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory | Buy | 6,000 | $2.20 | $13,200.00 | +25.0% | -44.2% | -81.8% | |
| Feb 4, 2025 | Owens David | Chief Medical Officer | Buy | 1,000 | $3.10 | $3,100.00 | +0.6% | -57.2% | -81.7% | |
| Feb 4, 2025 | Owens David | Chief Medical Officer | Buy | 1,000 | $2.98 | $2,980.00 | +0.7% | -57.2% | -81.7% | |
| Jan 28, 2025 | Owens David | Chief Medical Officer | Buy | 1,500 | $2.70 | $4,050.00 | +1.0% | -29.2% | -76.7% | |
| Jan 23, 2025 | Owens David | Chief Medical Officer | Buy | 3,000 | $2.57 | $7,700.00 | +1.0% | -32.7% | -76.7% | |
| Oct 28, 2024 | Owens David | Chief Medical Officer | Buy | 500 | $2.19 | $1,095.00 | +0.3% | +18.2% | -32.7% | |
| Aug 13, 2024 | Owens David | Chief Medical Officer | Buy | 1,000 | $0.95 | $950.00 | +0.7% | +247.9% | -12.7% | |
| Jun 28, 2024 | Owens David | Chief Medical Officer | Buy | 1,000 | $1.75 | $1,750.00 | +0.7% | -60.3% | -45.6% | |
| Jun 18, 2024 | Owens David | Chief Medical Officer | Buy | 1,619 | $0.71 | $1,149.49 | +1.1% | -36.5% | +7.7% | |
| Jun 10, 2024 | Owens David | Chief Medical Officer | Buy | 3,000 | $0.64 | $1,920.00 | +1.1% | +22.7% | +90.2% |